NCT02464865

Brief Summary

This study is aimed to assess the prevalence of thiamin deficiency in obese Thai children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P75+ for phase_4 obesity

Timeline
Completed

Started Aug 2015

Typical duration for phase_4 obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2015

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 8, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2015

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

October 2, 2018

Status Verified

September 1, 2018

Enrollment Period

2.9 years

First QC Date

May 18, 2015

Last Update Submit

September 28, 2018

Conditions

Keywords

thiamine deficiencyobese childrenThai

Outcome Measures

Primary Outcomes (1)

  • abnormal thiamin pyrophosphate effect

    Thiamin pyrophosphate effect will be measured by a blood test

    7 days

Secondary Outcomes (1)

  • consumption of thiaminase-containing foods and thiamin antagonist-containing foods

    7 days

Study Arms (3)

Thiamine 1

EXPERIMENTAL

presence of severe symptoms and signs of thiamine deficiency: heart failure, convulsion, coma, loss of ankle and knee jerks with muscular wasting and paralysis (typically symmetrical foot- and wrist-drop)

Drug: Thiamine 1

Non-thiamine

OTHER

no symptoms and signs of thiamine deficiency

Other: Non-thiamine

Thiamine 2

EXPERIMENTAL

presence of mild symptoms and signs of thiamine deficiency; peripheral neuropathy alone (paraesthesia of hands and feet)

Drug: Thiamine 2

Interventions

If severe symptoms and signs of thiamine deficiency are present, thiamine is prescribed. Intervention 1 : severe symptom (heart failure, convulsion, or coma) : 50 mg thiamin administered very slowly intravenously, followed by a daily intramuscular dose of 10 mg for a week, and finally followed by 3-5 mg of thiamine per day orally for at least 6 weeks

Thiamine 1

no symptoms and signs of thiamine deficiency

Non-thiamine

If symptoms and signs of thiamine deficiency are present, thiamine is prescribed. If mild symptom : a daily oral dose of 10 mg thiamin during the first week, followed by 3-5 mg of thiamin per day orally for at least 6 weeks

Thiamine 2

Eligibility Criteria

Age7 Years - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • obese : weight for height \> median + 3 standard deviations
  • simple obesity

You may not qualify if:

  • pathological obesity
  • chronic diseases e.g. cerebral palsy, metabolic disease, etc.
  • diseases of red blood cells
  • on medication e.g. steroid, multivitamins, thiamine-containing vitamins, diuretic drugs
  • hemodialysis or peritoneal dialysis
  • bariatric surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Siriraj Hospital

Bangkok, 10700, Thailand

Location

Related Publications (1)

  • Densupsoontorn N, Jirapinyo P, Kangwanpornsiri C. Micronutrient deficiencies in obese Thai children. Asia Pac J Clin Nutr. 2013;22(3):497-503. doi: 10.6133/apjcn.2013.22.3.06.

MeSH Terms

Conditions

ObesityThiamine Deficiency

Interventions

Thiamine

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsVitamin B DeficiencyAvitaminosisDeficiency DiseasesMalnutrition

Intervention Hierarchy (Ancestors)

ThiazolesSulfur CompoundsOrganic ChemicalsAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPyrimidines

Study Officials

  • Narumon Densupsoontorn, MD

    Mahidol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2015

First Posted

June 8, 2015

Study Start

August 1, 2015

Primary Completion

July 1, 2018

Study Completion

August 1, 2018

Last Updated

October 2, 2018

Record last verified: 2018-09

Locations